Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 30/07/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Myalepta, metreleptin, Date of authorisation: 30/07/2018, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Ruxience, rituximab, Date of authorisation: 01/04/2020, Revision: 14, Status: Authorised

Committee for Orphan Medicinal Products (COMP): 6-8 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2026 to 8 October 2026

Committee for Orphan Medicinal Products (COMP): 6-8 October 2026, European Medicines Agency, Amsterdam, the Netherlands, from 6 October 2026 to 8 October 2026

Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)

Ninth European Medicines Agency (EMA) and EFPIA bilateral meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 September 2026, 10:30 (CEST) to 16 September 2026, 12:30 (CEST)

Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Orladeyo, berotralstat, Date of authorisation: 30/04/2021, Revision: 11, Status: Authorised

Records of data processing activity relating to the management and processing of documents related to absences due to illness or accident and consultations with the occupational health physicians

Records of data processing activity relating to the management and processing of documents related to absences due to illness or accident and consultations with the occupational health physicians

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness